Red blood cell nitric oxide synthase activation is increased in patients with sickle cell hemoglobin C disease.
UMR Inserm U1134, Université des Antilles et de la Guyane, Pointe-à-Pitre, Guadeloupe, France; Laboratoire d'Excellence du Globule Rouge (LABEX GR-Ex), PRES Sorbonne, Paris, France.
Anaïs
A
Mozar
Marijke
M
Grau
Yann
Y
Lamarre
Linda
L
Weyel
Frank
F
Suhr
Bianca
B
Collins
Marie-Dominique
MD
Hardy-Dessources
Marc
M
Romana
Nathalie
N
Lemonne
Maryse
M
Etienne-Julan
Wilhelm
W
Bloch
Philippe
P
Connes
D016022:Case-Control Studies; D004789:Enzyme Activation; D004907:Erythrocyte Deformability; D004912:Erythrocytes / Q000201:enzymology* / Q000473:pathology; D005786:Gene Expression Regulation; D006450:Hemoglobin SC Disease / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D006801:Humans; D009569:Nitric Oxide / Q000378:metabolism*; D052250:Nitric Oxide Synthase Type III / Q000235:genetics / Q000378:metabolism*; D015398:Signal Transduction; D013049:Spectrin / Q000378:metabolism
D013049:Spectrin; D009569:Nitric Oxide; C496314:NOS3 protein, human; D052250:Nitric Oxide Synthase Type III